LGG-42. BEVACIZUMAB-ASSOCIATED SECONDARY AMENORRHEA AND PREMATURE OVARIAN FAILURE IN ADOLESCENT FEMALE PATIENTS WITH LOW-GRADE CNS DISEASE

Compelling body of evidence exists to use bevacizumab, a humanized monoclonal anti-VEGF antibody, in selected paediatric patients with low-grade CNS tumours. Common toxicities of bevacizumab, hypertension, proteinuria, epistaxis, mucosal perforation, decreased wound healing are well reported. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhukova, Nataliya, Chan, Kiri, Walshe, Kathryne, Downie, Peter A, Wood, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715379/
http://dx.doi.org/10.1093/neuonc/noaa222.421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715379/
http://dx.doi.org/10.1093/neuonc/noaa222.421

Ejemplares similares